Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This investigation is designed to compare lubiprostone and placebo for cleansing and propulsion in preparation for capsule endoscopy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of South Alabama
• Collaborators: Sucampo Pharmaceuticals, Inc.; Takeda
• Treatments: Lubiprostone

Criteria

Inclusion Criteria:

• Healthy volunteers

Exclusion Criteria:

• Gi disorders, gi surgery, cardiac, renal, or hepatic insufficiency, severe diarrhea